Key result
Drug-coated balloons demonstrate authentic efficacy in the treatment of coronary in-stent restenosis and offer a viable alternative for small vessel and bifurcation lesions.
This review highlights that while drug-coated balloons are effective for in-stent restenosis, their application in de novo coronary lesions remains controversial.
No takes yet. Share an insight, caveat, or question.
DCB may expand PCI options in select lesions; leaves open need for RCTs to guide adoption.
Gao et al. (2016) conducted a review in Coronary heart disease. Drug-coated balloon vs. Drug-eluting stents or plain balloon angioplasty was evaluated. Drug-coated balloons demonstrate authentic efficacy in the treatment of coronary in-stent restenosis and offer a viable alternative for small vessel and bifurcation lesions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: